Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Fengling Liu
Introduction
Fengling Liu is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer diagnosis and therapy. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Fengling Liu holds a patent for "Antibodies that bind tumor tissue for diagnosis and therapy." This innovative patent describes antibodies that interact with an extracellular RNA-protein complex to bind to tumor tissue. These antibodies are utilized in methods that induce an immune response and inhibit tumor cell growth. Additionally, the patent outlines methods for producing such antibodies, showcasing Liu's dedication to practical applications in medicine.
Career Highlights
Liu's career is marked by his role at Atreca, Inc., where he has been instrumental in advancing research and development in immunotherapy. His expertise in antibody development has positioned him as a key figure in the fight against cancer. With a focus on innovative solutions, Liu continues to contribute to the scientific community.
Collaborations
Fengling Liu collaborates with talented professionals in his field, including Jeff DeFalco and Daniel Eric Emerling. These partnerships enhance the research environment and foster innovation within Atreca, Inc.
Conclusion
Fengling Liu's work exemplifies the spirit of innovation in biotechnology. His patent for antibodies that target tumor tissue represents a significant advancement in cancer therapy. Through his career and collaborations, Liu continues to make impactful contributions to medical science.